Atomoxetine (Strattera®), behandeling ADHD


1. 1B-tekst atomoxetine (Strattera®) via: www.cbg-meb.nl, Geneesmiddeleninformatiebank. 
2. Michelson D, et al. Once-daily atomoxetine treatment for children and adolescents with attention-deficit hyperactivity disorder: a randomized, placebocontrolled, study. Am J Psychiatry 2002; 159: 1896-1901. 
3. Kelsey DK, et al. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics 2004; 114: e1-e8. 
4. Spencer T, et al. Results of proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2002; 63: 1140-1147. 
5. Weiss M, et al. A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. J Am Acad Child Adolesc Psychiatry 2005; 44: 647-655. 
6. CFH-rapport atomoxetine (Strattera®) via: www.cvz.nl, CFH-rapporten.  

Auteurs

  • dr D. Bijl